| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |